Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-027783

Chairman and CEO bought 4,000 shares at an average $1.32 ($5,260)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-05-05 Purchase +3,000 $1.32 $3,960 10,613,243 D
Niihara Yutaka Chairman and CEO 2020-05-06 Purchase +1,000 $1.30 $1,300 10,614,243 D
Open-market purchases · 4,000 sh · avg $1.32 · $5,260
Loading xslF345X03/doc4.xml…